MJ
INSIDER · PACS · PACS Group, Inc. · CO-FOUNDER, CEO & CHAIRMAN
Murray Jason Hulse
Every open-market transaction filed under this name, Aug 20 to Oct 21.
Filings
34
0 buys · 34 sells
Bought
—
open market, at cost
Sold
$25.5M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 21 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 6,610 | $47.62 | $315K | −1.8% |
| Oct 20 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 37,477 | $47.65 | $1.8M | −1.9% |
| Oct 19 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 1,620 | $47.57 | $77K | −1.7% |
| Oct 16 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 8,462 | $47.61 | $403K | −1.8% |
| Oct 15 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 3,062 | $48.11 | $147K | −2.8% |
| Oct 15 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 77,540 | $47.49 | $3.7M | −1.5% |
| Oct 15 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 24,800 | $46.78 | $1.2M | −0.1% |
| Oct 15 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 4,633 | $45.61 | $211K | +2.5% |
| Oct 14 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 232 | $45.00 | $10K | +3.9% |
| Oct 7 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 717 | $42.48 | $30K | +10.1% |
| Oct 6 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 7,222 | $43.64 | $315K | +7.2% |
| Oct 6 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 28,753 | $42.96 | $1.2M | +8.9% |
| Oct 5 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 24,224 | $42.66 | $1M | +9.6% |
| Oct 2 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 23,456 | $42.59 | $999K | +9.8% |
| Oct 2 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 2,596 | $41.79 | $108K | +11.9% |
| Oct 1 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 33,032 | $41.13 | $1.4M | +13.7% |
| Sep 14 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 317 | $45.03 | $14K | +3.8% |
| Sep 11 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 10,529 | $45.23 | $476K | +3.4% |
| Sep 10 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 8,771 | $45.16 | $396K | +3.5% |
| Sep 9 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 4,758 | $43.33 | $206K | +7.9% |
| Sep 8 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 21,001 | $43.59 | $916K | +7.3% |
| Sep 8 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 3,056 | $42.80 | $131K | +9.3% |
| Sep 4 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 243 | $43.14 | $10K | +8.4% |
| Sep 4 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 22,829 | $42.68 | $974K | +9.6% |
| Sep 3 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 858 | $43.11 | $37K | +8.5% |
| Sep 3 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 19,315 | $42.53 | $821K | +9.9% |
| Sep 2 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 6,348 | $43.36 | $275K | +7.8% |
| Sep 2 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 17,435 | $42.78 | $746K | +9.3% |
| Sep 1 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 1,368 | $43.05 | $59K | +8.6% |
| Sep 1 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 22,789 | $42.35 | $965K | +10.4% |
| Aug 21 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 27,590 | $44.25 | $1.2M | +5.7% |
| Aug 21 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 31,654 | $43.61 | $1.4M | +7.2% |
| Aug 20 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 13,879 | $44.76 | $621K | +4.5% |
| Aug 20 | PACS | PACS Group, Inc. | Co-Founder, CEO & Chairman | Sell | 77,427 | $43.77 | $3.4M | +6.8% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.